Psychosocial consequences of false positives in the Danish Lung Cancer CT Screening Trial: a nested matched cohort study
Jakob Fraes Rasmussen, Volkert Siersma, Jessica Malmqvist, John Brodersen, Jakob Fraes Rasmussen, Volkert Siersma, Jessica Malmqvist, John Brodersen
Abstract
Objectives: Lung cancer CT screening can reduce lung cancer mortality, but high false-positive rates may cause adverse psychosocial consequences. The aim was to analyse the psychosocial consequences of false-positive lung cancer CT screening using the lung cancer screening-specific questionnaire, Consequences of Screening in Lung Cancer (COS-LC).
Design and setting: This study was a matched cohort study, nested in the randomised Danish Lung Cancer Screening Trial (DLCST).
Participants: Our study included all 130 participants in the DLCST with positive CT results in screening rounds 2-5, who had completed the COS-LC questionnaire. Participants were split into a true-positive and a false-positive group and were then matched 1:2 with a control group (n=248) on sex, age (±3 years) and the time of screening for the positive CT groups or clinic visit for the control group. The true positives and false positives were also matched 1:2 with participants with negative CT screening results (n=252).
Primary outcomes: Primary outcomes were psychosocial consequences measured at five time points.
Results: False positives experienced significantly more negative psychosocial consequences in seven outcomes at 1 week and in three outcomes at 1 month compared with the control group and the true-negative group (mean ∆ score >0 and p<0.001). True positives experienced significantly more negative psychosocial consequences in one outcome at 1 week (mean ∆ score 2.86 (95% CI 1.01 to 4.70), p=0.0024) and in five outcomes at 1 month (mean ∆ score >0 and p<0.004) compared with the true-negative group and the control group. No long-term psychosocial consequences were identified either in false positives or true positives.
Conclusions: Receiving a false-positive result in lung cancer screening was associated with negative short-term psychosocial consequences. These findings contribute to the evidence on harms of screening and should be taken into account when considering implementation of lung cancer screening programmes.
Trial registration number: NCT00496977.
Keywords: computed tomography; preventive medicine; public health; thoracic medicine.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- Ott JJ, Ullrich A, Mascarenhas M, et al. . Global cancer incidence and mortality caused by behavior and infection. J Public Health 2011;33:223–33. 10.1093/pubmed/fdq076
- Shlomi D, Ben-Avi R, Balmor GR, et al. . Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J 2014;44:217–38. 10.1183/09031936.00164513
- National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409. 10.1056/NEJMoa1102873
- Humphrey LL, Deffebach M, Pappas M, et al. . Screening for lung cancer with low-dose computed tomography: a systematic review to update the US preventive services Task force recommendation. Ann Intern Med 2013;159:411–20. 10.7326/0003-4819-159-6-201309170-00690
- Pinsky PF, Church TR, Izmirlian G, et al. . The National lung screening trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013;119:3976–83. 10.1002/cncr.28326
- Manser R, Lethaby A, Irving LB, et al. . Screening for lung cancer. Cochrane Database Syst Rev 2013:CD001991. 10.1002/14651858.CD001991.pub3
- Winkler Wille MM, van Riel SJ, Saghir Z, et al. . Predictive accuracy of the PanCan lung cancer risk prediction model -external validation based on CT from the Danish lung cancer screening trial. Eur Radiol 2015;25:3093–9. 10.1007/s00330-015-3689-0
- Field JK, van Klaveren R, Pedersen JH, et al. . European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013;108:280–6. 10.1002/jso.23383
- Croswell JM, Baker SG, Marcus PM, et al. . Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med 2010;152:505–12. W176-80. 10.7326/0003-4819-152-8-201004200-00007
- Barton MB, Moore S, Polk S, et al. . Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med 2001;16:150–6. 10.1111/j.1525-1497.2001.00329.x
- Brodersen J, Jørgensen KJ, Gøtzsche PC. The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn 2010;120:89–94. 10.20452/pamw.895
- Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 2013;11:106–15. 10.1370/afm.1466
- Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 2008;28:917–25. 10.1177/0272989X08322013
- Goulart BHL, Bensink ME, Mummy DG, et al. . Lung cancer screening with low-dose computed tomography: costs, National expenditures, and cost-effectiveness. J Natl Compr Canc Netw 2012;10:267–75. 10.6004/jnccn.2012.0023
- Rasmussen JF, Siersma V, Pedersen JH, et al. . Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: a registry study. Lung Cancer 2014;83:347–55. 10.1016/j.lungcan.2013.12.005
- Jensen MD, Siersma V, Rasmussen JF, et al. . Direct and indirect healthcare costs of lung cancer CT screening in Denmark: a registry study. BMJ Open 2020;10:e031768. 10.1136/bmjopen-2019-031768
- Saghir Z, Dirksen A, Ashraf H, et al. . CT screening for lung cancer brings forward early disease. The randomised Danish lung cancer screening trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296–301. 10.1136/thoraxjnl-2011-200736
- Brodersen J, Thorsen H, Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health 2010;13:601–12. 10.1111/j.1524-4733.2010.00697.x
- van den Bergh KAM, Essink-Bot ML, Borsboom GJJM, et al. . Long-term effects of lung cancer computed tomography screening on health-related quality of life: the Nelson trial. Eur Respir J 2011;38:154–61. 10.1183/09031936.00123410
- Gareen IF, Duan F, Greco EM, et al. . Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National lung screening trial. Cancer 2014;120:3401–9. 10.1002/cncr.28833
- Brain K, Lifford KJ, Carter B, et al. . Long-term psychosocial outcomes of low-dose CT screening: results of the UK lung cancer screening randomised controlled trial. Thorax 2016;71:996–1005. 10.1136/thoraxjnl-2016-208283
- McCaffery KJ, Barratt AL. Assessing psychosocial/quality of life outcomes in screening: how do we do it better? J Epidemiol Community Health 2004;58:968–70. 10.1136/jech.2004.025114
- Pedersen JH, Ashraf H, Dirksen A, et al. . The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol 2009;4:608–14. 10.1097/JTO.0b013e3181a0d98f
- Andersen EB. A goodness of fit test for the Rasch model. Psychometrika 1973;38:123–40. 10.1007/BF02291180
- Dufouil C, Brayne C, Clayton D. Analysis of longitudinal studies with death and drop-out: a case study. Stat Med 2004;23:2215–26. 10.1002/sim.1821
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289–300. 10.1111/j.2517-6161.1995.tb02031.x
- Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ 2004;328:1470. 10.1136/bmj.38111.639734.7C
- Hestbech MS, Siersma V, Dirksen A, et al. . Participation bias in a randomised trial of screening for lung cancer. Lung Cancer 2011;73:325–31. 10.1016/j.lungcan.2010.12.018
- Grannis FW. Minimizing over-diagnosis in lung cancer screening. J Surg Oncol 2013;108:289–93. 10.1002/jso.23400
- Rasmussen JF, Siersma V, Pedersen JH, et al. . Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST). Lung Cancer 2015;87:65–72. 10.1016/j.lungcan.2014.11.003
- Saghir Z, Ashraf H, Dirksen A, et al. . Contamination during 4 years of annual CT screening in the Danish lung cancer screening trial (DLCST). Lung Cancer 2011;71:323–7. 10.1016/j.lungcan.2010.06.006
- Lindberg LG, Svendsen M, Dømgaard M, et al. . Better safe than sorry: a long-term perspective on experiences with a false-positive screening mammography in Denmark. Health Risk Soc 2013;15:699–716. 10.1080/13698575.2013.848845
- Kaerlev L, Iachina M, Pedersen JH, et al. . CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication. BMC Cancer 2012;12:188. 10.1186/1471-2407-12-188
- Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 2010;19:1026–34. 10.1002/pon.1676
- Kinsinger LS, Anderson C, Kim J, et al. . Implementation of lung cancer screening in the Veterans health administration. JAMA Intern Med 2017;177:399–406. 10.1001/jamainternmed.2016.9022
Source: PubMed